Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
VIPS Vipshop Holdings Ltd
CAT Caterpillar Inc
AAPL Apple Inc
ESLT Elbit Systems Ltd
AZO Autozone Inc
DITTF Daito Trust Construction Co Ltd
MYO Myomo Inc
CRVS Corvus Pharmaceuticals Inc
ARNC Arconic Corp (PITTSBURGH)
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Postmarket

Last Trade
Delayed
$145.00
0.11 (0.08%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$144.89
Day's Change
0.33 (0.23%)
Bid
--
Ask
--
B/A Size
--
Day's High
145.25
Day's Low
143.01
Volume
(Above Average)
Volume:
7,947,942

10-day average volume:
7,013,269
7,947,942

GE's Aviation unit to make 'permanent' job cuts as workforce is reduced 25% this year

9:57 am ET May 4, 2020 (MarketWatch)
Print

General Electric Co.'s (GE) Aviation business unit said Monday it is planning "permanent" job cuts that will bring its total workforce reductions to 25% in 2020. GE's stock fell 3.9% in morning trading. GE Aviation said the cuts come as global commercial airline traffic in the second quarter is expected to drop by about 80% from levels seen in early February as a result of the coronavirus pandemic. "Our aircraft manufacturers have announced reduced production schedules that will extend into 2021 and beyond reacting to the projected prolonged recovery," said GE Aviation Chief Executive David Joyce in a business update. "While extremely difficult, I am confident this is the required response to the continued contraction of the industry, and its protracted recovery." GE said last week when it reported first-quarter results (http://www.marketwatch.com/story/ge-burns-more-cash-than-expected-as-covid-19-takes-a-1-billion-bite-2020-04-29) that Aviation was developing a plan to cut costs by $1 billion and implement $2 billion of cash actions this year, including anticipated job cuts. GE expects the plans to be ready "over the coming months." GE's stock has shed 50.4% over the past three months while the Dow Jones Industrial Average has lost 18.6%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

May 04, 2020 09:57 ET (13:57 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.